Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117462) titled 'Yingtao Shujie Paste helps improve the efficacy and safety of breast nodule treatment in human clinical trials' on Jan. 23.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The Second Hospital of Anhui Medical University
Condition:
Diagnosed with breast nodules classified as BI-RADS category 2 or 3, and breast cancer has been ruled out
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-23
Target Sample Size: Trial group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304706
Publishe...